← FDA Drug Approvals (Drugs@FDA)

LEVOFLOXACIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HOSPIRA · Approved 2015-08-12

Drug application

FDA Application #

ANDA078577

Application type

Abbreviated New Drug Application (Generic)

Brand name

LEVOFLOXACIN

Generic name

Levofloxacin

Active ingredients

LEVOFLOXACIN

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Discontinued

Sponsor

HOSPIRA

First approval

2015-08-12

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown